Clinical characteristics of subjects with symptoms of α1- antitrypsin deficiency older than 60 years

Chest

Volumn 135, Issue 3, 2009, Pages 600-608

  Campos, Michael A ^a   Alazemi, Saleh ^a   Zhang, Guoyan ^b   Salathe, Matthias ^a   Wanner, Adam ^a   Sandhaus, Robert A ^c   Baier, Horst ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b Miami Dade Health Department   (United States)

^c AlphaNet   (United States)

Author keywords

Age groups; COPD; Quality of life

Indexed keywords

ADULT; AGE; AGED; ALPHA 1 ANTITRYPSIN DEFICIENCY; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL FEATURE; DISEASE COURSE; DISEASE EXACERBATION; FEMALE; FOLLOW UP; FORCED EXPIRATORY VOLUME; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; QUALITY OF LIFE; SMOKING; SMOKING CESSATION; SYMPTOM;

EID: 62149113261     PISSN: 00123692     EISSN: 19313543     Source Type: Journal    
DOI: 10.1378/chest.08-1129     Document Type: Article

References (33)

1. 1-antitrypsin deficiency. Am J Respir Crit Care Med 2003; 168:818-900
2. 1-antitrypsin deficiency: a continuing problem. Chest 2005; 128:1989-1994
3. 1-antitrypsin deficiency of adults with pulmonary symptoms. Am Rev Respir Dis 1988; 138:327-336
4. 1-antitrypsin deficiency, Pi Z. Acta Med Scand 1978; 204:345-351
5. 1-protease inhibitor. Chest 2001; 119:737-744
6. 1-antitrypsin deficiency in the elderly. Postgrad Med J 1991; 67:840-842
7. 1-Antitrypsin deficiency presenting with panniculitis and incidental discovery of chronic obstructive pulmonary disease. Int J Dermatol 2007; 46:1078-1080
8. Jones PW, Quirk FH, Baveystock CM, et al. A self-complete measure of health status for chronic airflow limitation: the St. George's Respiratory Questionnaire. Am Rev Respir Dis 1992; 145:1321-1327
9. Ware JE, Snow KK, Kosinski M. SF-36 health survey: manual and interpretation guide. Lincoln, RI: QualityMetric Incorporated, 2002
10. Desikan R, Mason HL, Rupp MT, et al. Health-related quality of life and healthcare resource utilization by COPD patients: a comparison of three instruments. Qual Life Res 2002; 11:739-751
11. Anie KA, Jones PW, Hilton SR, et al. A computer-assisted telephone interview technique for assessment of asthma morbidity and drug use in adult asthma. J Clin Epidemiol 1996; 49:653-656
12. Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease (GOLD). Available at: www.goldcopd.org. Accessed October 25, 2008
13. Ware JE, Kosinski M, Dewey JE. How to score version 2 of the SF-36 health survey. Lincoln, RI: QualityMetric Incorporated, 2002
14. Rodriguez-Roisin R. Toward a consensus definition for COPD exacerbations. Chest 2000; 117(suppl):398S-401S
15. Jones PW. St. George's respiratory questionnaire: MCID. COPD 2005; 2:75-79
16. 1-antitrypsin deficiency: clinical correlates. Ann Intern Med 1989; 111:982-991
17. 1-antitrypsin. Am J Respir Crit Care Med 1998; 158:49-59
18. 1-antitrypsin deficiency. Lancet 1985; 1:152-154
19. 1-antitrypsin deficiency (PiZZ). Eur Respir J 1999; 13:247-251
20. 1-antitrypsin deficiency. Thorax 1998; 53:265-268
21. 1-antitrypsin deficiency with special reference to non-index cases. Thorax 1994; 49:695-698
22. 1-antitrypsin deficiency type PiZ. Am J Respir Crit Care Med 1995; 152:1922-1925
23. Tobin MJ, Cook PJ, Hutchison DC. Alpha 1-antitrypsin deficiency: the clinical and physiological features of pulmonary emphysema in subjects homozygous for Pi type Z: a survey by the British Thoracic Association. Br J Dis Chest 1983; 77:14-27
24. 1-antitrypsin deficiency. Am J Respir Crit Care Med 2000; 162:553-558
25. 1- antitrypsin deficiency. Acta Paediatr 1998; 87:1120-1124
26. 1-antitrypsin deficiency (PiZZ). Thorax 1997; 52:244-248
27. 1-antitrypsin deficiency: experience of the National Heart, Lung, and Blood Institute Registry. Chest 2003; 123:765-771
28. Esteban C, Quintana JM, Aburto M, et al. A simple score for assessing stable chronic obstructive pulmonary disease.Q J Med 2006; 99:751-759
29. Miravitlles M, Ferrer M, Pont A, et al. Effect of exacerbations on quality of life in patients with chronic obstructive pulmonary disease: a 2-year follow-up study. Thorax 2004; 59:387-395
30. Spencer S, Calverley PM, Burge PS, et al. Impact of preventing exacerbations on deterioration of health status in COPD. Eur Respir J 2004; 23:698-702
31. Jones PW, Bosh TK. Quality of life changes in COPD patients treated with salmeterol. Am J Respir Crit Care Med 1997; 155:1283-1289
32. Miravitlles M, Ferrer M, Pont A, et al. Characteristics of a population of COPD patients identified from a population-based study: focus on previous diagnosis and never smokers. Respir Med 2005; 99:985-995
33. 1-antitrypsin (AAT) augmentation therapy with prolastin. Am J Respir Crit Care Med 2008; 177:A419